Plasma zinc concentrations are depressed during the acute phase response in children with falciparum malaria

Christopher Duggan1, William B MacLeod, Nancy F Krebs

  • 1Division of Gastroenterology and Nutrition, Children's Hospital, Boston, MA, USA.

Insights

In children with acute malaria, low plasma zinc is common and linked to inflammation and parasite levels. Zinc supplementation effectively increased plasma zinc concentrations.

Area of Science:

  • Nutritional biochemistry
  • Infectious disease research
  • Pediatric health

Background:

  • Plasma micronutrient levels can change during acute illness and inflammation.
  • Conflicting data exists on plasma zinc changes during the acute phase response.

Purpose of the Study:

  • To investigate the relationship between plasma zinc concentration and the acute phase response in children with acute falciparum malaria.
  • To evaluate the impact of zinc supplementation on plasma zinc levels in this population.

Main Methods:

  • Observational cohort study of 689 children in a randomized zinc supplementation trial for acute malaria.
  • Plasma zinc measured using atomic absorption spectrophotometry.
  • Multivariate analysis to identify predictors of plasma zinc levels and changes.

Main Results:

  • 70% of subjects had low admission plasma zinc (<9.2 micromol/L).
  • Admission C-reactive protein (CRP), parasite density, and study site predicted admission plasma zinc.
  • Baseline CRP, change in CRP, treatment group, study site, and baseline zinc predicted changes in plasma zinc.
  • Plasma zinc was inversely correlated with CRP and parasitemia.
  • Zinc supplementation increased plasma zinc concentrations from admission to 72 hours.

Conclusions:

  • Low plasma zinc is prevalent in children with acute malaria and correlates with inflammation and parasitemia.
  • Plasma zinc interpretation requires consideration of acute phase markers like CRP.
  • Oral zinc supplementation is beneficial for increasing plasma zinc in at-risk children with malaria.

Related Concept Videos

Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...